ATE197295T1 - Benzoxazinone als inhibitoren von reverser trans- kriptase von hiv - Google Patents

Benzoxazinone als inhibitoren von reverser trans- kriptase von hiv

Info

Publication number
ATE197295T1
ATE197295T1 AT93306114T AT93306114T ATE197295T1 AT E197295 T1 ATE197295 T1 AT E197295T1 AT 93306114 T AT93306114 T AT 93306114T AT 93306114 T AT93306114 T AT 93306114T AT E197295 T1 ATE197295 T1 AT E197295T1
Authority
AT
Austria
Prior art keywords
hiv
benzoxazinones
inhibitors
treatment
methods
Prior art date
Application number
AT93306114T
Other languages
English (en)
Inventor
Steven D Young
Lekhanh O Tran
Susan F Britcher
William C Lumma Jr
Linda S Payne
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26733517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE197295(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE197295T1 publication Critical patent/ATE197295T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93306114T 1992-08-07 1993-08-03 Benzoxazinone als inhibitoren von reverser trans- kriptase von hiv ATE197295T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92660792A 1992-08-07 1992-08-07
US5480593A 1993-04-27 1993-04-27

Publications (1)

Publication Number Publication Date
ATE197295T1 true ATE197295T1 (de) 2000-11-15

Family

ID=26733517

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93306114T ATE197295T1 (de) 1992-08-07 1993-08-03 Benzoxazinone als inhibitoren von reverser trans- kriptase von hiv

Country Status (36)

Country Link
EP (1) EP0582455B1 (de)
JP (1) JPH0780860B2 (de)
KR (1) KR100272387B1 (de)
CN (3) CN1318031C (de)
AT (1) ATE197295T1 (de)
AU (1) AU670300B2 (de)
BG (1) BG62612B1 (de)
CA (1) CA2101572C (de)
CZ (1) CZ290447B6 (de)
DE (4) DE122008000034I1 (de)
DK (1) DK0582455T3 (de)
DZ (1) DZ1707A1 (de)
ES (1) ES2151897T3 (de)
FI (2) FI115457B (de)
GR (1) GR3034754T3 (de)
HR (1) HRP931102B1 (de)
HU (1) HU223076B1 (de)
IL (1) IL106507A (de)
LU (2) LU90709I2 (de)
LV (1) LV12719B (de)
MX (1) MX192812B (de)
MY (1) MY109834A (de)
NL (2) NL300032I2 (de)
NO (3) NO304886B1 (de)
NZ (1) NZ255216A (de)
PL (2) PL176679B1 (de)
PT (1) PT582455E (de)
RO (1) RO113641B1 (de)
RU (1) RU2186775C2 (de)
SG (1) SG52698A1 (de)
SI (1) SI9300419B (de)
SK (1) SK282276B6 (de)
TW (2) TW382014B (de)
UA (1) UA42699C2 (de)
WO (1) WO1994003440A1 (de)
YU (1) YU49439B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one
US6147210A (en) 1996-07-26 2000-11-14 Dupont Pharmaceuticals Company Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors
AU3736197A (en) * 1996-07-26 1998-02-20 Du Pont Pharmaceuticals Company A practical synthesis of benzoxazinones useful as hiv reverse transcripta se inhibitors
ZA9711256B (en) 1996-12-16 1999-06-15 Du Pont Merck Pharma Asymmetric synthesis of benzoxazinones
US5932726A (en) * 1996-12-16 1999-08-03 Dupont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones
US5965729A (en) 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
DE69841972D1 (de) * 1997-02-05 2010-12-09 Merck Sharp & Dohme Verfahren zur kristallisation eines reverstranskriptase-inhibitors, bei welchem ein anti-lösungsmittel benutzt wird
CA2285000A1 (en) * 1997-04-07 1998-10-15 Dupont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones via new intermediates
US6124302A (en) * 1997-04-09 2000-09-26 Dupont Pharmaceuticals 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
PL338894A1 (en) * 1997-09-03 2000-11-20 Merck & Co Inc Method of increasing optical purity of 2r-[1-hydroxy-1-trifluoromethy-3-cyclopropylopropin-2-yl]-4-chloroaniline
US5952528A (en) * 1997-09-03 1999-09-14 Merck & Co., Inc. Process for enhancing the optical purity
US20010014352A1 (en) 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
HRP990182A2 (en) * 1998-06-11 2000-02-29 Du Pont Pharm Co Crystalline efavirenz
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
WO2000000475A1 (en) * 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
SE9904652D0 (sv) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US6946469B2 (en) 2001-03-28 2005-09-20 Bristol-Myers Squibb Pharma Company Cyanamide, alkoxyamino, and urea derivatives of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones as HIV reverse transcriptase inhibitors
WO2004085406A1 (en) 2003-03-24 2004-10-07 F. Hoffmann-La Roche Ag Benzyl-pyridazinons as reverse transcriptase inhibitors
AR048650A1 (es) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
AR056652A1 (es) * 2005-04-11 2007-10-17 Tibotec Pharm Ltd Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento
WO2009044788A1 (ja) * 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
GB0720503D0 (en) 2007-10-22 2007-11-28 Angeletti P Ist Richerche Bio New compound
WO2011000532A2 (de) 2009-07-03 2011-01-06 Archimica Gmbh Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren
EP3351249A1 (de) 2010-01-27 2018-07-25 VIIV Healthcare Company Antivirale therapie
EP2471783A1 (de) 2010-12-23 2012-07-04 Esteve Química, S.A. Neuartige polymorphe Form von Efavirenz
CN103664816B (zh) * 2011-01-06 2016-03-02 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺
CN102675125B (zh) * 2011-03-15 2015-02-18 中国科学院上海有机化学研究所 一种4-氯-2-三氟乙酰基苯胺及其类似物的简便高效合成方法
JP7071036B2 (ja) 2019-02-15 2022-05-18 福建永晶科技股▲ふん▼有限公司 Ｆｒｉｅｄｅｌ－Ｃｒａｆｔｓ反応の新しい新方法及び当該方法に用いられる触媒
CN110372625B (zh) * 2019-08-06 2022-11-01 常州大学 蓝光照射制备4-烷甲基-4-芳基-1,3-苯并噁嗪-2(4h)-酮的方法
CN113106473B (zh) * 2021-04-14 2022-02-18 南京工业大学 一种通过连续电化学微反应器装置制备1,3-苯并噁嗪衍生物的方法
EP4416134A4 (de) * 2021-10-15 2025-09-10 Merck Sharp & Dohme Llc Benzoxazinonderivate als selektive cytotoxische mittel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3562621A (en) * 1967-07-26 1971-02-09 Technipower Inc Inrush current limiting circuit for rectifier circuits with capacitive load
DE3217012A1 (de) * 1982-05-06 1983-11-10 Dr. Karl Thomae Gmbh, 7950 Biberach Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
HRP931102A2 (en) 1997-10-31
LU90709I2 (fr) 2002-02-04
SI9300419A (en) 1994-06-30
SG52698A1 (en) 1998-09-28
NZ255216A (en) 1996-05-28
BG62612B1 (bg) 2000-03-31
TW382014B (en) 2000-02-11
DK0582455T3 (da) 2000-11-27
SI9300419B (sl) 2002-10-31
EP0582455A1 (de) 1994-02-09
NO2008008I1 (no) 2008-06-30
EP0582455B1 (de) 2000-11-02
CN1221608A (zh) 1999-07-07
CN1107505C (zh) 2003-05-07
AU670300B2 (en) 1996-07-11
PT582455E (pt) 2001-03-30
NO950424L (no) 1995-04-06
CA2101572A1 (en) 1994-02-08
CN1318031C (zh) 2007-05-30
FI115457B (fi) 2005-05-13
DE122008000034I1 (de) 2008-10-02
NL300347I1 (nl) 2008-07-01
KR950702970A (ko) 1995-08-23
CN1090277A (zh) 1994-08-03
NL300032I2 (nl) 2001-04-02
ES2151897T3 (es) 2001-01-16
FI20040309A7 (fi) 2004-02-27
JPH0780860B2 (ja) 1995-08-30
MY109834A (en) 1997-08-30
WO1994003440A1 (en) 1994-02-17
DZ1707A1 (fr) 2002-02-17
YU49439B (sh) 2006-03-03
UA42699C2 (uk) 2001-11-15
LV12719B (lv) 2001-12-20
LU91446I2 (fr) 2008-07-28
NO950424D0 (no) 1995-02-06
FI950508A0 (fi) 1995-02-06
KR100272387B1 (ko) 2000-11-15
RU95107403A (ru) 1996-11-20
JPH06184124A (ja) 1994-07-05
MX9304775A (es) 1994-05-31
AU4449693A (en) 1994-02-10
RO113641B1 (ro) 1998-09-30
HRP931102B1 (en) 2001-06-30
BG99383A (bg) 1995-09-29
LV12719A (lv) 2001-09-20
MX192812B (es) 1999-07-30
IL106507A (en) 1997-11-20
HUT71219A (en) 1995-11-28
CA2101572C (en) 2001-08-28
TWI233436B (en) 2005-06-01
RU2186775C2 (ru) 2002-08-10
FI950508L (fi) 1995-02-06
CN1250652A (zh) 2000-04-19
SK16195A3 (en) 1995-07-11
NO304886B1 (no) 1999-03-01
CZ28695A3 (en) 1995-09-13
NO2000004I1 (no) 2000-06-16
DE69329608D1 (de) 2000-12-07
YU53093A (sh) 1996-10-09
IL106507A0 (en) 1993-11-15
DE10199013I1 (de) 2001-05-23
SK282276B6 (sk) 2002-01-07
CZ290447B6 (cs) 2002-07-17
HU223076B1 (hu) 2004-03-01
NL300032I1 (de) 2001-02-01
GR3034754T3 (en) 2001-02-28
PL176679B1 (pl) 1999-07-30
DE10199013I2 (de) 2007-05-24
HK1009267A1 (en) 1999-05-28
PL307348A1 (en) 1995-05-15
CN1051767C (zh) 2000-04-26
PL175615B1 (pl) 1999-01-29
DE69329608T2 (de) 2001-05-03
HU9500366D0 (en) 1995-03-28

Similar Documents

Publication Publication Date Title
DE69329608D1 (de) Benzoxazinone als Inhibitoren von reverser Trans-Kriptase von HIV
DE69228106D1 (de) HIV-Protease-Inhibitoren
ATE230610T1 (de) Hiv protease hemmer in pharmazeutischen zusammensetzungen zur behandlung von aids
DE69430385D1 (de) Hiv-proteaseinhibitoren
DK0774969T3 (da) HIV-proteaseinhibitor kombination
FI970565A0 (fi) HIV-proteaasia inhiboiva yhdistelmä